APA (7th ed.) Citation

Weaver, J. D., Stack, E. C., Buggé, J. A., Hu, C., McGrath, L., Mueller, A., . . . Zhang, Y. (2022). Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. OncoImmunology, 11(1), 1. https://doi.org/10.1080/2162402X.2022.2141007

Chicago Style (17th ed.) Citation

Weaver, Jessica D., et al. "Differential Expression of CCR8 in Tumors Versus Normal Tissue Allows Specific Depletion of Tumor-infiltrating T Regulatory Cells by GS-1811, a Novel Fc-optimized Anti-CCR8 Antibody." OncoImmunology 11, no. 1 (2022): 1. https://doi.org/10.1080/2162402X.2022.2141007.

MLA (9th ed.) Citation

Weaver, Jessica D., et al. "Differential Expression of CCR8 in Tumors Versus Normal Tissue Allows Specific Depletion of Tumor-infiltrating T Regulatory Cells by GS-1811, a Novel Fc-optimized Anti-CCR8 Antibody." OncoImmunology, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1080/2162402X.2022.2141007.